1,682
Views
46
CrossRef citations to date
0
Altmetric
Retracted Article

RETRACTED ARTICLE: Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer

, , , , &
Pages 290-297 | Received 29 Jun 2014, Accepted 10 Jul 2014, Published online: 11 Aug 2014
 

Abstract

We, the Editors and Publisher of the journal Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article:

Eommolbanin Ebrahimi, Abolfazl Akbarzadeh, Elham Abbasi, Amir Ahmad Khandaghi, Farhad Abasalizadeh & Soodabeh Davaran (2016) Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer. Artificial Cells, Nanomedicine, and Biotechnology, 44(1), 290–297, DOI: 10.3109/21691401.2014.944646

Since publication, a reader alerted the Publisher that Figures 5, 6 and 7 appear to have been previously published in Artificial Cells, Nanomedicine, and Biotechnology and other journals, specifically:

  • Figure 5 appears to have been duplicated with Figure 6 from Ebrahimi et al., 2014 (https://doi.org/10.3109/21691401.2014.968822).

  • Figure 6 appears to have been duplicated with Figure 7 from Ebrahimi et al., 2014 (https://doi.org/10.3109/21691401.2014.968822)

  • Figure 6 appears to have been duplicated with Figure 11 from Akbarzadeh et al., 2012 (https://doi.org/10.2147/IJN.S24326)

  • Figure 7 appears to have been duplicated with Figure 8 from Ebrahimi et al., 2014 (https://doi.org/10.3109/21691401.2014.968822).

The reused images have been described as originating from a new study with no reference to the previous studies. We contacted the corresponding author and second author, and they acknowledged the similarities in the data published. As this error directly impacts the reported results and conclusions, the Editor and Publisher have agreed to retract the article to ensure correction of the scholarly record. The corresponding author has been informed.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

View retraction statement:
Statement of Retraction

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.